In our study, the Endocan level, a newly identified marker of endothelial dysfunction, was found to be significantly elevated in the patient group with hyperprolactinemia. Although numerous studies have established a correlation between elevated…
Endocan levels in patients with hyperprolactinemia | BMC Endocrine Disorders
